Insights
Impact Global Health Dialogues
There is an urgent need for informed and representative voices to co-create an R&D investment roadmap that is fit for the future. We are launching a 12-month series of dialogues with global health leaders across sectors and around the world to build this roadmap. Join us!
We need effective, sustainable and equitable R&D funding
At Impact Global Health we believe that a better world starts with more equitable global health. But we are facing one of the most turbulent and challenging environments in global health for decades with major public funders announcing decreased spending and a mature pipeline of products for neglected diseases which need to reach the finishing line and to be replenished in order to benefit from the huge health and economic impacts we see from global health R&D.
We invite you to join other global health leaders to take part in our dialogues on the future of global health R&D investment. We invite you to bring your experiences, lessons, ambitions and observations to the table and hope you’ll also enjoy listening to those of others. Our role in facilitating these dialogues is as a partner, collaborator and counsel, with a deep background in data analysis and insights on the funding, pipeline and impact of the global health R&D landscape.
Register your interest
Sign up to let us know you'd like to take part in a dialogue and we'll be in touch to confirm a suitable time and date for you
Online dialogues calendar
See when the next online dialogues are scheduled
In-person dialogues calendar
See when the next in-person dialogues are scheduled
We will publish the outcomes and key messages from each dialogue as a blog post and will use these to co-design, with the global health community, an R&D investment roadmap at the end of the series.
Latest dialogueYou may be interested in
40 min read
The 2025 Neglected Disease R&D Pipeline review: Time to close the gaps
Amid reduced funding, political uncertainty, and rising infectious disease, this report assesses the health of the neglected diseases (ND) pipeline to empower funders, policymakers, and advocates to prioritize high impact investments. This report delves into a decade of ND pipeline insights to guide future investment strategies.
45 min read
A New Era? Funding for sexual & reproductive health R&D 2018-2023
This is the fourth in a series of reports summarising the state of global funding for LMIC-applicable biomedical research and development targeting a range of sexual & reproductive health and women’s health issues
5 min read
Neglected disease funders
Who was funding what in 2023 and what does this mean for the future?
5 min read
Funding by disease
How much R&D funding for which diseases did we see in 2023?
5 min read
Making a stand for global health
Our CEO, Dr Nick Chapman, responds to the US withdrawal from global health programmes and shares how Impact Global Health is leading conversations to shape a sustainable future.
